Tecnovatica S.A. (WSE:TEC)

Market Cap	5.05M -48.5%
Revenue (ttm)	52.62K +163.1%
Net Income	69.77K
EPS	0.01
Shares Out	10.75M
PE Ratio	72.41
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	95,754
Average Volume	184,155
Open	0.5400
Previous Close	0.5400
Day's Range	0.4600 - 0.5550
52-Week Range	0.2280 - 0.9000
Beta	0.07
RSI	49.89
Earnings Date	Mar 27, 2026

About Tecnovatica

Tecnovatica S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation. The company was formerly known as Vinci Gen S.A. and changed its name to Tecnovatica S.A. in ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: TEC